HIV-1 gp120-gp41广

Evan M Cale1, Chen-Hsiang Shen1, Adam S Olia1

  • 1Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Cell reports
|December 15, 2024
PubMed
概括

研究人员确定了VRC44,一种广泛中和抗体 (bNAb) 血统,向HIV-1包膜 (Env) 三分体. 这一发现验证了基于生殖线的免疫原设计,用于开发有效的HIV-1疫苗.